ARCHIVES

In Brief: NSABP Proposal Selected for Tamoxifen Trials; NIH Building To Be Named After Silvio Conte

This article is from The Cancer Letter archive.

Vol. 17 No. 10 | March 8, 1991

Download PDF Visit The Full Archive

Related Articles

Bristol-Myers Squibb To Purchase DuPont Pharmaceuticals For $7.8 Billion.

June 29, 2001

NIH Grantees Win Nobel Prizes In Medicine, Chemistry

October 9, 2009

HHS System Of Misconduct investigation Not Suited For Clinical Trials, Broder Says

November 11, 1994

Oblimersen Combination Improves CLL Survival

December 28, 2007

New Technology May Enable Therapy Tailored To Patient’s Predicted Response

April 26, 2002

Trials Approved by NCI CTEP For the Month of May

May 25, 2012